Comparison of the Effectiveness of Piperacillin-Tazobactam and Carbapenems in Nosocomial Infections with Extended-Spectrum Beta-lactamase-Producing Escherichia coli and Klebsiella pneumoniae

Abstract

Introduction: Infections with extended-spectrum beta-lactamase (ESBL)-producing strains are seen at increasing rates, resulting in increased morbidity, mortality, length of hospitalization, and cost. Effective and safe treatment of these infections is important. The aim of this study was to compare the effectiveness of piperacillin-tazobactam (PTZ) and carbapenems in nosocomial infections with ESBL-producing Escherichia coli and Klebsiella pneumoniae in hospitalized patients. Materials and Methods: This study was performed retrospectively on patients who were infected with ESBL-producing E. coli and K. pneumoniae while hospitalized in Ankara Atatürk Tranining and Research Hospital between 2014 and 2017. Both PTZ- and carbapenem-susceptible isolates were included in the study. Patients with signs of infection who were older than 18 years, hospitalized for at least 48 hours, and received PTZ or carbapenem therapy were included in the study. Patients who received PTZ and carbapenem antibiotics consecutively in same infectious episode, received another antibiotic active against ESBL-producing microorganisms, received the selected antibiotic for less than 48 hours, or had polymicrobial infection were excluded from the study. Demographic characteristics, comorbid diseases, antibiotics used and their dose/duration, mechanical ventilation, presence of central catheter, clinical and microbiological responses to treatment, and end-of-treatment and 30-day mortality were recorded and compared. Results: Of the total 113 patients, 60 (53.1%) were male and the mean age was 66.14±18.2 years. Of the patients, 73.5% had E. coli and 26.5% had K. pneumoniae. Seventy patients (61.9%) received carbapenem and 43 patients (38.1%) received PTZ treatment. Microbiological eradication rate was 71.7% (43/60) in patients with control cultures. Clinical response was observed in 72.6% of the cases. The overall mortality rate was 31.0% (n=35). There were no significant differences between the groups in clinical and microbiological response (p=0.055; p=0.303) or end-of-treatment and 30-day mortality (p=0.180, p=0.288). Age and bacteremia was found to be independent risk factors for mortality (p=0.006 for both). Conclusion: PTZ is an important alternative for infections caused by ESBL-producing microorganisms. In recent years, the need for rational antibiotic use has increased and carbapenem-sparing treatments have became more important. Piperacillin-tazobactam is one of the best alternatives and has comparable effectiveness in infections caused by ESBL-producing E. coli and Klebsiella spp.

Authors and Affiliations

Müge AYHAN, Bircan KAYAASLAN, İmran HASANOĞLU, Ayşe KAYA KALEM, Dilek ASİLTÜRK, Mehmet Akın TAŞYARAN, Hatice Rahmet GÜNER

Keywords

Related Articles

Ocular Brucellosis: Case Report and Literature Review

Brucellosis is a systemic zoonotic infection transmitted to humans by contact with the body fluids of infected animals or consumption of infected animal products. Although nearly eradicated in many developed countries, t...

What to Know About Travel Related Infections

Travel is as old as human history. People travel for purposes such as migration, commerce, education, missionary activity, and entertainment. Historically, these human movements gave rise to geographical discoveries, tra...

Acinetobacter baumannii Biofilm: Intervening Factors, Persistence, Drug Resistance, and Strategies of Treatment

Acinetobacter baumannii (A. baumannii) is a Gram-negative opportunistic and nosocomial pathogen that is associated with most of the hospital epidemics. Its success can be directly attributed to its ability to survive und...

Inguinal Flap Implementation In Diabetic Hand Infection With Complicated Invasive Candidiasis

Although hand infections in diabetic patients are observed less frequently than foot infections, hand infections may cause severe problems, such as stiffness and loss of skin, nerve and bone persisting even after the inf...

Download PDF file
  • EP ID EP689256
  • DOI 10.4274/mjima.galenos.2020.2020.3
  • Views 186
  • Downloads 0

How To Cite

Müge AYHAN, Bircan KAYAASLAN, İmran HASANOĞLU, Ayşe KAYA KALEM, Dilek ASİLTÜRK, Mehmet Akın TAŞYARAN, Hatice Rahmet GÜNER (2020). Comparison of the Effectiveness of Piperacillin-Tazobactam and Carbapenems in Nosocomial Infections with Extended-Spectrum Beta-lactamase-Producing Escherichia coli and Klebsiella pneumoniae. Mediterranean Journal of Infection, Microbes and Antimicrobials, 9(1), -. https://europub.co.uk/articles/-A-689256